Handelsavisen
prelaunch
NU
NURT.BO BSE (India) Food Retail & Distribution

Nurt.Bo

$31,12
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
8,6 %
ROE
21,7 %
Net margin
7,4 %
Debt / equity
0,01
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Nurtures is a food and drug retailing company operating in the Consumer Non-Cyclicals sector, primarily generating revenue through the sale of food and drug products to consumers.

Business. Nurtures is a food and drug retailing company operating in the Consumer Non-Cyclicals sector, primarily generating revenue through the sale of food and drug products to consumers.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Drug Retailing
IndustryFood Retail & Distribution
ActivityFood & Drug Retailing
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
21,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning NURT.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to NURT.BO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Nurtures is a food and drug retailing company operating in the Consumer Non-Cyclicals sector, primarily generating revenue through the sale of food and drug products to consumers.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Drug Retailing
    IndustryFood Retail & Distribution
    ActivityFood & Drug Retailing
    AI synthesis
    GENERATED

    Nurtures maintains a strong liquidity position, as evidenced by a current ratio of 1.61, indicating that the company has sufficient current assets to cover its current liabilities. The company's liquidity is further supported by a low debt-to-equity ratio of 0.01, suggesting minimal reliance on debt financing and a strong equity base. The operating cash flow of INR 480.9 million and free cash flow of INR 65.93 million indicate that the company generates positive cash from operations, which can be used for reinvestment or shareholder returns.

    In terms of profitability, Nurtures demonstrates a return on equity (ROE) of 21.69% and a return on assets (ROA) of 11.69%, both of which are strong indicators of efficient use of equity and assets to generate profits. These metrics are particularly significant in the Food Retail & Distribution industry, where margins are typically compressed due to competitive pricing and high operational costs. The company's gross profit of INR 1.03 billion and operating income of INR 659.5 million further support its profitability.

    Nurtures operates primarily in the food and drug retailing segment, with a focus on domestic markets. The company's revenue is concentrated in this segment, and there is no indication of significant geographic diversification in the provided data. This concentration may expose the company to regional economic fluctuations and regulatory changes, which could impact its overall performance.

    The company's growth trajectory is supported by its strong operating cash flow and free cash flow, which provide flexibility for expansion and investment. However, the absence of detailed revenue history and outlook data makes it challenging to assess the company's future growth potential. The company's capital expenditure of INR -34 million suggests that it is not currently investing heavily in new projects or infrastructure, which may limit its ability to scale operations.

    Nurtures faces a medium liquidity risk, as indicated by the risk assessment, and the company has a negative net cash position after accounting for total debt. The dilution risk could not be assessed due to the absence of basic and diluted share counts, which is a limitation in evaluating potential shareholder dilution. The company's low debt levels and strong equity position mitigate some of these risks, but the lack of detailed information on capital structure and shareholder dilution remains a concern.

    There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial performance. The absence of recent transcripts or filings suggests that the company may not be actively communicating with investors or disclosing material developments, which could affect investor confidence and market perception.

    Key takeaways
    • Nurtures has a strong liquidity position with a current ratio of 1.61 and a low debt-to-equity ratio of 0.01.
    • The company demonstrates high profitability with a return on equity of 21.69% and a return on assets of 11.69%.
    • Nurtures' revenue is concentrated in the food and drug retailing segment, with no significant geographic diversification.
    • The company's growth trajectory is supported by positive operating and free cash flows, but the lack of detailed revenue history limits the assessment of future growth potential.
    • Nurtures faces a medium liquidity risk and an unassessable dilution risk due to missing share count data.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $31,12
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $2.60B
    Net cash
    -$15.8M
    Current ratio
    1.6
    Debt / equity
    0.0
    ROA
    11.7%
    ROE
    21.7%
    Cash conversion
    85.0%
    CapEx / revenue
    -0.4%
    SBC / revenue
    Dilution ratio

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskUnknown
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin8,6 %Above P75
    Net Margin7,4 %Best in class
    ROE21,7 %Best in class
    Capex / Rev-0,4 %Above P75
    D/E0,01Above P75
    Cash Conv0,85Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • NURT.BO Market data — financials · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    NURT.BOCanonical
    BSE (India) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskUnknown
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage